MVRBF - Medivir AB reports 1H results
2023-08-18 14:38:37 ET
More on Medivir AB
- Medivir starts dosing in mid-stage study of fostrox/Lenvima combo for liver cancer
- Infex's antibiotic MET-X gets FDA infectious disease product status
- Medivir's liver drug MIV-818 gets generic name fostroxacitabine bralpamide
- Medivir posts results from investigator-initiated mid-stage carcinoma study
- Earnings data for Medivir AB
For further details see:
Medivir AB reports 1H results